EU-210

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameEU-210
Drug Alias NameWT1 4-1BB CTL adoptive T cell therapy (Eutilex)WT1 T Cell Therapy (Eutilex)WTiNTEU-210
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionWilms' Tumour 1 modulators
TargetsWilms' Tumour 1
Therapy Area/IndicationsSolid tumoursGliomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEuropeSouth Korea +[5] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPreclinical
Originator CompaniesEutilex
China Registration ClassN/A

Develop Information

Active CompaniesEutilex
Inactive CompaniesN/A
Active IndicationsSolid tumoursGliomaNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A